Vorapaxar in the secondary prevention of atherothrombotic events
: Morrow DA, Braunwald E, Bonaca MP, Ameriso SF, Dalby AJ, Fish MP, Fox KA, Lipka LJ, Liu X, Nicolau JC, Ophuis AJ, Paolasso E, Scirica BM, Spinar J, Theroux P, Wiviott SD, Strony J, Murphy SA
: 2012
New England Journal of Medicine
: 366
: 12
: 366
: 144
: 1413
: 0028-4793